Company news

Lipocine Inc. news in 2023

Lipocine Inc.'s news releases, calls and decks from 2023, newest first.

View company

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

November 12, 2023

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

November 7, 2023

Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023

October 31, 2023

Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum Depression

October 25, 2023

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023

August 9, 2023

LPCN 1148 Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis

July 26, 2023

Lipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023

June 6, 2023

Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression

May 15, 2023

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023

May 10, 2023

Lipocine Announces Pro Rata Distribution of Series B Preferred Stock to its Holders of Common Stock

March 9, 2023

Lipocine Announces Financial Results for the Year Ended December 31, 2022

March 9, 2023

Decks in 2023